Autolus Therapeutics plc AUTL
$ 2.27
1.12%
Quarterly report 2024-Q3
added 12-21-2024
Country |
Britain |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Christian Martin Itin |
Employees in the company |
290 |
Shares |
174 M |
Market Cap[1] |
$ 395 M |
EBITDA (LTM) |
$ -201 M |
P/E (LTM) |
-2.2 |
P/S (LTM) |
- |
EPS (LTM) |
-1.03 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.